Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,397 across all filing types
Latest filing 2019-12-23 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Enhertu (trastuzumab deruxtecan) approved in US
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated December 23, 2019. The content details the US FDA approval of a drug (Enhertu) by AstraZeneca and Daiichi Sankyo, including clinical trial data, safety information, and financial milestone payments. The document concludes with standard boilerplate text referencing RNS, the London Stock Exchange, and the Financial Conduct Authority, and ends with 'END'. This structure is characteristic of a regulatory news service announcement, specifically one disseminated via RNS (Regulatory News Service). Since the content is a specific announcement of a regulatory event (FDA approval) and financial consequence, it fits best under the general 'Regulatory Filings' category (RNS) as it is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA).
2019-12-23 English
ASTRAZENECA DIVESTS RIGHTS TO ARIMIDEX AND CASODEX IN EUROPE AND CERTAIN ADDITIO
Regulatory Filings
2019-12-20 English
AstraZeneca divests rights to Arimidex and Casodex
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement disseminated via the London Stock Exchange's RNS service. The content describes a specific corporate action: AstraZeneca divesting commercial rights for two established drugs (Arimidex and Casodex) to Juvisé Pharmaceuticals for a financial consideration. This is a material event announcement concerning asset disposal and financial updates, but it is not a full financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). Since it is a specific, material corporate announcement distributed via RNS that doesn't fit the other specific categories (like DIRS, DIV, CAP, or TAR), the most appropriate classification is the general regulatory filing category, RNS, as it is explicitly branded as an RNS release.
2019-12-20 English
FDA PANEL BACKS LYNPARZA USE FOR PANCREATIC CANCER
Regulatory Filings
2019-12-17 English
FDA panel backs Lynparza use for pancreatic cancer
Legal Proceedings Report Classification · 99% confidence The document is identified by the 'RNS Number' header and contains a date stamp (17 December 2019 18:00 GMT). The content is a press release announcing a positive recommendation from the FDA's Oncologic Drugs Advisory Committee (ODAC) regarding the drug Lynparza for pancreatic cancer. This type of announcement, which disseminates material, time-sensitive information to the market via an official regulatory channel (RNS), fits the definition of a general regulatory announcement that doesn't fit a more specific financial report category (like 10-K, ER, or IR). Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is substantial (18,797 chars), so it is not a short announcement of a report (RPA).
2019-12-17 English
SEROQUEL RIGHTS AGREEMENT COMPLETE: EUROPE, RUSSIA
Regulatory Filings
2019-12-16 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.